蛋白聚糖和ADAMTS-1在多囊卵巢综合征患者血清中的表达及其临床意义

doi:10.13481/j.1671-587x.20190232

摘要/Abstract

摘要： 目的：探讨蛋白聚糖（Versican）和Ⅰ型血小板结合蛋白基序的解聚蛋白样金属蛋白酶（ADAMTS-1）在多囊卵巢综合征（PCOS）患者血清中的表达，阐明二者在PCOS发病中的作用。方法：选取80例PCOS患者（PCOS组）和100名正常体检妇女（对照组）为研究对象，测量2组受试对象身高和体质量，计算体质量指数（BMI）；采用酶联免疫吸附试验（ELISA）法检测2组受试对象血清中Versican和ADAMTS-1水平，测定2组受试对象血清中卵泡刺激素（FSH）、黄体生成激素（LH）、睾酮（T）、空腹血糖（FBG）和空腹胰岛素等水平；采用胰岛素抵抗指数稳态模式评估法（HOMA-IR）评估胰岛素抵抗。采用Pearson直线相关分析法分析Versican和ADAMTS-1与代谢指标的相关性。结果：PCOS组患者血清中Versican水平低于对照组（P=0.004），PCOS组患者血清中ADAMTS-1水平低于对照组（P<0.01）。Versican和ADAMTS-1预测PCOS的灵敏度、特异度、受试者工作特征（ROC）曲线下面积（AUC）分别为76.74% vs 63.64%（P=0.018）、52.94% vs 40.73%（P=0.009）和0.675（0.550~0.795）vs 0.714（0.601~0.827）（P=0.032）。PCOS组患者Versican水平与FBG水平呈负相关关系（r=-0.738，P=0.022），ADAMTS-1水平与FBG水平亦呈负相关关系（r=-0.524，P=0.043）。结论：Versican和ADAMTS-1在PCOS患者外周血中低表达，并与胰岛素抵抗呈负相关关系，在PCOS发生中可能起抑制作用。

关键词: 蛋白聚糖, Ⅰ型血小板结合蛋白基序的解聚蛋白样金属蛋白酶, 多囊卵巢综合征, 胰岛素抵抗, 空腹血糖

Abstract: Objective: To determine the expressions of Versican and a distintegrin and metalloprotease with thrombospondin type 1 motifs(ADAMTS-1) in serum in the polycystic ovary syndrome (PCOS) patients, and to clarify their roles in the pathogenesis of PCOS.Methods: A total of 80 patients with PCOS (PCOS group) and 100 healthy women (control group) were selected.The heights and body weights of the subjects in two groups were measured; and the body mass index(BMI) was calculated.The levels of serum Versican and ADAMTS-1 of the subjects in two groups were measured by enzyme-linked immunosorbent assay(ELISA) method.The levels of serum follicle stimulating hormone(FSH),luteinizing hormone(LH),testosterone(T),fasting blood glucose(FBG),fasting insulin of the subjects in two groups were detected; insulin resistance was evaluated according to Homeostasis Model Assessment of Insulin Resistance (HOMA-IR).The correlations between Versican,ADAMTS-1 and the metabolic indexes were analyzed by Pearson linear correlation analysis.Results: The serum Versican level of the paticnts in PCOS group was significantly decreased compared with control group (P=0.004);the serum ADAMTS-1 level was also decreased (P<0.01). The sensitivities,the specificities and the area under receiver operating characteristic (ROC) curve (AUC) of Versican and ADAMTS-1 in prediction of PCOS were 76.74% vs 63.64% (P=0.018),52.94% vs 40.73% (P=0.009) and 0.675 (0.550-0.795) vs 0.714(0.601-0.827) (P=0.032), respectively. The correlation analysis showed that in PCOS group the serum level of Versican of the patients was negatively correlated with FBG(r=-0.738,P=0.022), and ADAMTS-1 was negatively correlated with FBG(r= -0.524,P=0.043).Conclusion: Versican and ADAMTS-1 lowly express in the patients with PCOS. They are negatively correlated with the insulin resistance.They may play inhibitory effects in the occurrence of PCOS.

Key words: Versican, a distintegrin and metalloprotease with thrombospondin type 1 motifs, polycystic ovary syndrome, insulin resistance, fasting blood glucose

中图分类号:

R711.75

金爱红, 周霞平, 余志英. 蛋白聚糖和ADAMTS-1在多囊卵巢综合征患者血清中的表达及其临床意义[J]. 吉林大学学报(医学版), 2019, 45(02): 400-404.

JIN Aihong, ZHOU Xiaping, YU Zhiying. Expressions of Versican and ADAMTS-1 in polycysticovary syndrome patients and their clincal significances[J]. Journal of Jilin University(Medicine Edition), 2019, 45(02): 400-404.

参考文献

[1] LI R, ZHANG Q F, YANG D Z, et al. Prevalence of polycystic ovary syndrome in women in China:A large community based study[J]. Hum Reprod, 2013, 28(9):2562-2569.
[2] LAURITSEN M P, BENTZEN J G, PINBORG A, et al.The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone[J].Hum Reprod, 2014, 29(4):791-801.
[3] AANDERSSON-SJÖLAND A,HALLGREN O,ROLANDSSON S,et al.Versican in inflammation and tissue remodeling:the impact on lung disorders[J].Glycobiology, 2015, 25(3):243-251.
[4] ZHENG X L.Structure-function and regulation of ADAMTS-13 protease[J].J Thromb Haemost, 2013, 11(Suppl 1):11-23.
[5] 陈梅,张玲.多能蛋白聚糖在卵巢和子宫中功能的研究进展[J].中国计划生育和妇产科,2015,7(11):14-17.
[6] TORTORELLA M, PRATTA M, LIU R Q, et al.The thrombospondin motif of aggrecanase-1(ADAMTS-4) is critical for aggrecan substrate recognition and cleavage[J].J Biol Chem, 2000, 275(33):25791-25797.
[7] SOUTH K, FREITAS M O, LANE D A.Conformational quiescence of ADAMTS-13 prevents proteolytic promiscuity[J].J Thromb Haemost, 2016, 14(10):2011-2022.
[8] XIAO S, LI Y, LI T, et al.Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients[J].J Clin Endocrinol Metab, 2014, 99(6):E1015-E1021.
[9] ÖZLER S, ÖZTA E Ş, TOKMAK A, et al.Role of Versican and ADAMTS-1 in polycystic ovary syndrome[J].J Clin Res Pediatr Endocrinol, 2017, 9(1):24-30.
[10] TOLA E N, KARATOPUK D U, KOROGLU N, et al.Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome[J].J Assist Reprod Genet,2017,34(6):811-816.
[11] RUSSELL D L, BROWN H M, DUNNING K R.ADAMTS proteases in fertility[J].Matrix Biol,2015,5(44):54-63.
[12] TOLA E N, KARATOPUK D U, KOROGLU N, et al.Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome[J].J Assist Reprod Genet,2017,34(6):811-816.
[13] TOLA E N, KOROGLU N D, YALCIN S E, et al.The role of serum ADAMTS-1 and aggrecan on polycystic ovary syndrome in adolescents and younger-aged females[J].Arch Gynecol Obstet,2018,297(2):487-493.
[14] KARAKOSE M, DEMIRCAN K, TUTAL E, et al.Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome[J].J Endocrinol Invest,2016,39(11):1269-1275.
[15] FOULCER S J,DAY A J,APTE S S.Isolation and purification of versican and analysis of versican proteolysis[J].Methods Mol Biol, 2015, 1229(6):587-604.
[16] RUSSELL D L, DOYLE K M H, OCHSNER S A, et al.Processing and localization of ADAMTS-1 and proteolytic cleavage of Versican during cumulus matrix expansion and ovulation[J].J Biol Chem, 2003, 278(43):42330-42339.
[17] SANDY J D, WESTLING J, KENAGY R D, et al.Versican V₁proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond,a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4[J].J Biol Chem, 2001, 276(16):13372-13378.
[18] NANDADASA D, FOULCER S, APTE S S.The multiple,complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis[J].Matrix Biol,2014, 35(5):34-41.
[19] HOSSEINPANAH F, BARZIN M, ERFANI H, et al.Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study[J].Clin Endocrinol (Oxf), 2014, 81(1):52-57.
[20] NASCIMENTO J X, CHEIN M B, DE SOUSA R M, et al.Importance of lipid accumulation product index as a marker of CVD risk in PCOS women[J].Lipids Health Dis, 2015, 24(14):62.
[21] TRIMECHÈ S, THUAN DIT DIEUDONNE J F,JEANDEL C, et al.Polycystic ovary syndrome in pubertal period:clinical,biological,metabolic and genetic polymorphism[J].Gynecol Obstet Fertil, 2004, 32(1):3-17.
[22] 赵君利,陈子江,石玉华,等.育龄期妇女体毛状况调查及其在多囊卵巢综合征诊断中的初步应用[J].中华妇产科杂志,2007,42(9):590-594.